NCT04216524 2026-03-04
Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
M.D. Anderson Cancer Center
Phase 2 Recruiting
M.D. Anderson Cancer Center
Immune Oncology Research Institute
MacroGenics
Institute of Hematology and Blood Transfusion, Czech Republic